Anatara Lifesciences Stock Fundamentals
| ANR Stock | 0.06 0 1.72% |
Anatara Lifesciences fundamentals help investors to digest information that contributes to Anatara Lifesciences' financial success or failures. It also enables traders to predict the movement of Anatara Stock. The fundamental analysis module provides a way to measure Anatara Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anatara Lifesciences stock.
At this time, Anatara Lifesciences' Interest Expense is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 1.6 M in 2024, despite the fact that Gross Profit is likely to grow to (711.5 K). Anatara | Select Account or Indicator |
Anatara Lifesciences Company Shares Outstanding Analysis
Anatara Lifesciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Anatara Lifesciences Shares Outstanding | 207.89 M |
Most of Anatara Lifesciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anatara Lifesciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Anatara Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Anatara Lifesciences has 207.89 M of shares currently outstending. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all Australia stocks is notably lower than that of the firm.
Anatara Lifesciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Anatara Lifesciences's current stock value. Our valuation model uses many indicators to compare Anatara Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anatara Lifesciences competition to find correlations between indicators driving Anatara Lifesciences's intrinsic value. More Info.Anatara Lifesciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anatara Lifesciences' earnings, one of the primary drivers of an investment's value.Anatara Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anatara Lifesciences' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anatara Lifesciences could also be used in its relative valuation, which is a method of valuing Anatara Lifesciences by comparing valuation metrics of similar companies.Anatara Lifesciences is currently under evaluation in shares outstanding category among its peers.
Anatara Fundamentals
| Return On Equity | -1.27 | ||||
| Return On Asset | -0.59 | ||||
| Operating Margin | 2.85 % | ||||
| Current Valuation | 10.56 M | ||||
| Shares Outstanding | 207.89 M | ||||
| Shares Owned By Insiders | 29.97 % | ||||
| Shares Owned By Institutions | 12.89 % | ||||
| Price To Book | 8.68 X | ||||
| Price To Sales | 6.31 X | ||||
| Revenue | (123.18 K) | ||||
| Gross Profit | (1.6 M) | ||||
| EBITDA | (1.46 M) | ||||
| Net Income | (1.45 M) | ||||
| Total Debt | 306.85 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (1.25 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 1.79 | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 11.85 M | ||||
| Total Asset | 1.67 M | ||||
| Retained Earnings | (22.09 M) | ||||
| Working Capital | 1.37 M | ||||
| Net Asset | 1.67 M |
About Anatara Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anatara Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anatara Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anatara Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -23.8 K | -24.9 K | |
| Cost Of Revenue | 748.9 K | 786.4 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.